期刊文献+

产教融合背景下制药产业技能人才培养的路径

The Path of Cultivating Skilled Talents in the Pharmaceutical Industry under the Background of Industry Education Integration
下载PDF
导出
摘要 制药产业快速发展,产业不断升级和开放,迈向国际化和智能。对产业技能人才需求扩大且提出了新的要求。在产教融合背景下,制药产业技能人才的培养路径愈发多元。归纳制药产业发展趋势,比较各国家制药产业技能人才培养特色,指出产教融合背景下制药产业技能人才可以通过扩大办学规模、建设产教联合体和共同体、开设产业学院等路径进行培养,为我国医药产业政策制定和发展决策提供参考人才支撑依据。 The pharmaceutical industry is developing rapidly,constantly upgrading and opening up,moving towards internationalization and intelligence.The demand for industrial skilled talents has expanded and new requirements have been put forward.In the context of the integration of industry and education,the training paths for skilled talents in the pharmaceutical industry are becoming increasingly diverse.Summarize the development trend of the pharmaceutical industry,compare the characteristics of cultivating skilled talents in the pharmaceutical industry in various countries,and point out that under the background of industry education integration,skilled talents in the pharmaceutical industry can be cultivated through expanding the scale of education,building industry education consortiums and communities,and establishing industrial colleges,providing reference and talent support for policy formulation and development decision-making in China's pharmaceutical industry.
作者 黎玄哲 Li Xuanzhe(Yueyang Vocational Technical College,Yueyang 41400,China)
出处 《广东化工》 CAS 2024年第16期236-237,221,共3页 Guangdong Chemical Industry
基金 湖南省“十三五”教育科学规划一般课题(XJK18CZY077) 2022年度湖南省社会科学成果评审委员会课题(XSP22YBZ186)。
关键词 产教融合 制药产业 人才培养 integration of industry and educations pharmaceutical industry personnel training
  • 相关文献

参考文献5

二级参考文献39

  • 1万里,孙劲楠,丁佐奇,郝海平.产学研合作模式下长三角生物医药产业一体化协同创新发展研究——基于专利合作及基金项目合作[J].中国药科大学学报,2022,53(6):742-752. 被引量:7
  • 2何兵明,邱友春,陈捷,张福利.盐酸多奈哌齐的合成[J].中国医药工业杂志,2005,36(11):657-659. 被引量:8
  • 3张福利,邱友春,何兵明.一种制备1-苄基-4-哌啶甲醇的方法:中国,1939907[P].2005-09-30.
  • 4周国斌,唐鹤,管月清,等.合成4-AA的中间体及其制备方法和用途:中国,102336696[P].2011-07-15.
  • 5ABPI ( 2011 ), Delivering Value to the UK : The contribution of the pharmaceutical industry to patients, the NHS and the economy.
  • 6MHRA (2005), The medicines for human use ( manufacturing, wholesale dealing and miscellaneous amendments) regulations.
  • 7HM Government ( 2012 ), Strength and Opportunity 2012: The landscape of the medical technology, medical biotechnology, industrial biotechnology and pharmaceutical sectors in the UK.
  • 8HM Government (2012), Strategy for UK life sciences : one year on.
  • 9BIS ( Department for Business Innovation & Skills) (2011 ), Strategy for UK life sciences.
  • 10ABPI (2011), Facts and figures about the pharmaceutical industry in the UK.

共引文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部